These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7378421)

  • 1. Inhibition of dopamine-beta-hydroxylase by alternative electron donors.
    Rosenberg RC; Gimble JM; Lovenberg W
    Biochim Biophys Acta; 1980; 613(1):62-72. PubMed ID: 7378421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of alternate substrates to probe the order of substrate addition to dopamine beta-hydroxylase.
    Fitzpatrick PF; Harpel MR; Villafranca JJ
    Arch Biochem Biophys; 1986 Aug; 249(1):70-5. PubMed ID: 3740855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of dopamine beta-monooxygenase by external and internal electron donors in resealed chromaffin granule ghosts.
    Ahn NG; Klinman JP
    J Biol Chem; 1987 Feb; 262(4):1485-92. PubMed ID: 3805036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purification of dopamine-beta-monooxygenase and extremely acidic, copper-containing proteins from the adrenal medulla. Extremely acidic, copper-containing proteins as electron donors for dopamine-beta-monooxygenase].
    Boiadzhian AS
    Biokhimiia; 1985 Jan; 50(1):84-90. PubMed ID: 3978154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of membrane-bound dopamine beta-hydroxylase from the cytoplasmic surface of the chromaffin-granule membrane.
    Grouselle M; Phillips JH
    Biochem J; 1982 Mar; 202(3):759-70. PubMed ID: 7092843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dopamine-beta-hydroxylase, A copper enzyme, by bleomycin.
    Matsui H; Kato T; Yamamoto C; Takita T; Takeuchi T; Umezawa H; Nagatsu T
    J Antibiot (Tokyo); 1980 Apr; 33(4):435-40. PubMed ID: 6157665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
    Aunis D; Miras-Portugal MT; Mandel P
    Biochem Pharmacol; 1973 Oct; 22(20):2581-9. PubMed ID: 4763594
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism-based inhibitors of dopamine beta-hydroxylase: inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    Biochemistry; 1984 Jul; 23(16):3590-8. PubMed ID: 6477886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anion- and pH-dependent activation of the soluble form of dopamine beta-hydroxylase.
    Terland O; Flatmark T
    Biochem J; 2003 Feb; 369(Pt 3):675-9. PubMed ID: 12379149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alternate reductant binding and electron transfer in the dopamine beta-monooxygenase reaction.
    Stewart LC; Klinman JP
    Biochemistry; 1987 Aug; 26(17):5302-9. PubMed ID: 3676254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An acidic copper-containing protein as a mediator at the stage of electron transfer from cytochrome b-561 to dopamine-beta-monooxygenase].
    Oganesian LL; Boiadzhian AS; Petrosian SA; Mkrtchian ME; Karagezian KG
    Dokl Akad Nauk SSSR; 1991; 317(3):742-5. PubMed ID: 1954845
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of dopamine-beta-monooxygenase with lipids: 1. Lipids as modulators of the catalytic activity of the enzyme.
    Boyadzhyan AS; Karagezyan KG
    Biomed Sci; 1990 Apr; 1(4):379-83. PubMed ID: 2133056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ascorbic acid in dopamine beta-hydroxylation. The endogenous enzyme cofactor and putative electron donor for cofactor regeneration.
    Menniti FS; Knoth J; Diliberto EJ
    J Biol Chem; 1986 Dec; 261(36):16901-8. PubMed ID: 3097015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dopamine beta-hydroxylase by some new thiourea derivatives.
    Oyama H; Izumi H; Ozawa H
    Biochem Pharmacol; 1976 Feb; 25(3):277-80. PubMed ID: 1267825
    [No Abstract]   [Full Text] [Related]  

  • 18. Superoxide anion as a cofactor of dopamine-beta-hydrxylase.
    Henry JP; Hirata F; Hayaishi O
    Biochem Biophys Res Commun; 1978 Apr; 81(4):1091-9. PubMed ID: 27181
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1593-600. PubMed ID: 6693426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.